Abstract
While the use of radioimmunotherapy for lymphoma increases, the feasibility and efficacy of autologous stem cell transplant for subsequent relapse remains unknown. We report a 48-year-old male with transformed follicular mixed non-Hodgkin's lymphoma. After treatment with three different combination chemotherapy regimens, at relapse he received radioimmunotherapy with iodine 131I tositumomab (anti-CD20), with very good response. At later relapse, a second course of 131I tositumomab was given unsuccessfully. He underwent peripheral blood stem cell harvest, chemoradiotherapy conditioning and autologous transplantation with prompt engraftment and without significant complications. He remains in complete remission with normal blood counts 25 months post autograft.
Bone Marrow Transplantation (2002) 29, 523–525. doi:10.1038/sj.bmt.1703398
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hubbard SM, Chabner BA, DeVita VT Jr et al. Histologic progression in non-Hodgkin's lymphoma Blood 1982 59: 258 264
Chen CI, Crump M, Tsang R et al. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma Br J Haematol 2001 113: 202 208
Williams CD, Harrison CN, Lister TA et al. European Bone Marrow Transplant Lymphoma Working Party. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry J Clin Oncol 2001 19: 727 735
Press OW, Eary JF, Gooley T et al. A phase I–II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas Blood 2000 96: 2934 2942
Kaminiski MS, Estes J, Zasadny KR et al. Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience Blood 2000 96: 1259 1266
Vose JM, Wahl RL, Saleh M et al. Multicenter phase II study of iodine-131 tositumomab for chemotherapy relapsed or refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphoma J Clin Oncol 2000 18: 1316 1323
Witzig TE, White CA, Wiseman GA et al. Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma J Clin Oncol 1999 12: 3793 3803
Leone G, Mele L, Pulsoni A et al. L The incidence of secondary leukemias Haematologica 1999 84: 937 945
Metayer C, Curtis RE, Sobocinski KA et al. Myelodysplastic syndrome (MDS) and leukemia after autotransplantation for lymphoma: a multicenter case-control study. Oral Presentation No. 23 Proc ASCO 2001 20: 7a
Park S, Brice P, Noguerra ME et al. Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies Bone Marrow Transplant 2000 26: 321 326
Stone RM, Neuberg D, Soiffer R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 1994 12: 2535 2542
Milligan DW, Ruiz de Elvira CM, Kolb H-J et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation Br J Haematol 1999 106: 1020 1026
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cooney, J., Stiff, P. & Kaminski, M. Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine 131I tositumomab). Bone Marrow Transplant 29, 523–525 (2002). https://doi.org/10.1038/sj.bmt.1703398
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703398